Just Kwit: Mobile Intervention for Tobacco Cessation
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The investigators will recruit hospitalized young adult smokers aged 18-30 interested in cessation over a six-month period. Patients will all receive a UPMC Tobacco Treatment Service counseling session focused on motivational interviewing prior to participation in the study. Upon consent, participants will then be randomized 1:1 to either standard patient-initiated follow-up or use of the Kwit app. Participants will be stratified by sex because males and females are known to have highly variable responses to existing tobacco control interventions. Investigators will systematically assess feasibility using established Likert-type items factors such as interaction, features, engagement, trust, and impact.
If a participant consents to the study, they will be given a brief survey to collect general information related to their smoking behavior. After 30 days, a follow-up survey will be conducted to assess their current smoking behavior. Participants randomized to the experimental arm will be asked additional questions about their use of the smartphone app.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, États-Unis, 15213
- UPMC
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 18-30 smokers interested in cessation (>5 cigarettes/day over the past 30 days)
- Must own an Apple or Android based smartphone.
Exclusion Criteria:
- Already receiving pharmacological and/or behavioral intervention or counseling for smoking cessation.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Kwit app
Use of Kwit smartphone app
|
Kwit smarphone app
|
|
Aucune intervention: Standard of care
Patient initiated follow-up post discharge
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
Délai: 1-month
|
Assessment of feasibility - Descriptive statistics that will be obtained via a follow up survey will be used to assess feasibility. The follow up survey will be administered one month after discharge via email, phone or in-person, determined by the preference of the participant. Specific questions will be asked asking participants to rate the Kwit smartphone application based on helpfulness, ease of use, and to list frustrations and helpful aspects of the application. How helpful was the Kwit app? Very helpful Somewhat helpful Neutral Not very helpful Not at all helpful Was the app easy to use? Very Somewhat Neutral Not much Not at all Was it frustrating to use? Very Somewhat Neutral Not much Not at all What, if anything, was helpful about the app? What, if anything, was not helpful about the app? |
1-month
|
|
Feasibility - Frequency of Use
Délai: 1-month
|
Assessment of feasibility - Descriptive statistics that will be obtained via a follow up survey will be used to assess feasibility.
The follow up survey will be administered one month after discharge via email, phone or in-person, determined by the preference of the participant.
Specific questions will be asked asking participants to rate the Kwit smartphone application based on frequency of use.
|
1-month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cessation--point Prevalence Abstinence
Délai: 1-month
|
Assessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. Since you left the hospital in (month/year), have you smoked a cigarette (even a puff)? In the past 30 days, have you smoked a cigarette, even a puff? In the past 7 days, have you smoked a cigarette, even a puff? |
1-month
|
|
Cessation--cigarettes Smoked
Délai: 1-month
|
Assessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. (On the days you smoked), how many cigarettes on average did you smoke (even a puff)? |
1-month
|
|
Cessation--days Smoked
Délai: 1-month
|
Assessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. In the past 30 days, on how many days did you smoke (even a puff)? |
1-month
|
|
Cessation--confidence
Délai: 1-month
|
Assessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. How confident are you that you will be able to stay quit? |
1-month
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- PRO18010454
- K07CA222338 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Kwit smartphone app
-
Paris Nanterre UniversityComplétéSevrage tabagique | TCC | Engagement | Modèle d'acceptation de la technologieFrance
-
Northwestern UniversityAmerican Cancer Society, Inc.ComplétéCancer du seinÉtats-Unis
-
Zealand University HospitalComplétéHernie inguinale | ConvalescenceDanemark
-
Leiden University Medical CenterMedical Center Haaglanden; Groene Hart Ziekenhuis; Reinier de Graaf Groep; Alrijne... et autres collaborateursRecrutementAVC aigu | Triage préhospitalier | Traitement de l'AVC | Code d'AVCPays-Bas
-
Fundación Pública Andaluza para la gestión de la...Actif, ne recrute pas
-
Alnylam PharmaceuticalsRecrutementAngiopathie Amyloïde CérébraleCanada
-
Ministry of Science and Technology, TaiwanFu Jen Catholic UniversityRecrutementConditions infantiles | Allaitement maternel | Anxiété post-partumTaïwan
-
Idego srlComplétéAuto-efficacité | MotivationItalie
-
National Taiwan University HospitalRecrutement